肝硬化患者在哪里死亡? 一个疾病预防控制中心的奇迹分析从1999年到2020年
Areej Iftikhar1, Fatima Noor Alam2, Danish Ali Ashraf3
1Department of Medicine Allama Iqbal Medical College Lahore Pakistan.
概括
肝硬化死亡人数显著增加,特别是在2019-2020年. 大多数死亡发生在医疗机构,男性,白人和55-64岁的人群的死亡率更高.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 老年学是一门学科.
背景情况:
- 肝硬化是全球主要的健康问题,患病率和死亡率不断增加.
- 关于患者死亡地点的地理和人口差异存在重大知识差距.
- 了解这些趋势对于有针对性的公共卫生干预至关重要.
研究的目的:
- 分析1999年至2020年美国肝硬化患者死亡地点的趋势.
- 确定与肝硬化死亡率相关的人口和地理因素.
- 为制定预防性和息性护理策略提供信息.
主要方法:
- 一项描述性研究,使用来自CDC WONDER数据库 (1999-2020) 的死亡证明数据.
- 分析包括ICD代码K70.3,K71.7和K74用于肝硬化相关的死亡.
- 检查的变量:年份,性别,年龄,种族,农村-城市状态,人口普查地区和州.
主要成果:
- 在1999年至2020年期间,发生了超过100万例肝硬化死亡,在2019-2020年有显著的增加.
- 大多数死亡发生在住院医疗机构 (48.75%),其次是家庭 (25.71%).
- 在男性,白人人口,55-64岁年龄组和南部人口普查地区的居民中观察到较高的死亡率.
结论:
- 肝硬化死亡率呈现上升趋势,特别是在最近几年.
- 特定的人口群 (男性,白人,55-64岁) 和地理区域 (南方) 面临更高的风险.
- 研究结果强调,需要量身定制的干预措施来解决肝硬化护理和生命终结结果的差异.
相关概念视频
01:21Cancer Survival Analysis
457
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
457
01:20Comparing the Survival Analysis of Two or More Groups
297
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
297
01:09Censoring Survival Data
248
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
248
01:20Actuarial Approach
138
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
138
01:26Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
01:24Kaplan-Meier Approach
276
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
276